New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

Increased risk for suicide may be associated with head injuries, highlighting the connection between head trauma and ...

FDA grants Priority Review to AXS-05 (dextromethorphan/bupropion) for the treatment of agitation associated with Alzheimer disease.

Long-term research indicates that anorexia nervosa onset in adolescence predicts higher psychiatric outpatient care and medication use.

Widespread misinterpretation of instructions for patients on a health questionnaire highlights the need for more clear patient communication.

Pharmacist-directed medical cannabis programs may serve as a replacement for prescription opioids in chronic pain management.

Among pregnant individuals, the rate of opioid-related diagnoses has increased and appears to be associated with increased risk for morbidity.

The FDA has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1).

This is a syndicated post stub.

Circadian rhythms that are weaker, more fragmented, or easily disrupted may be associated with increased risk for dementia.

Study finds that increased carotid stenosis severity is linked to significantly worse processing speed and executive function in older adults.

Social inclusion clusters in first-episode psychosis were identified among patients, linking higher participation to better quality of life.